Common side effects for both agents include nausea, vomiting, and diarrhoea, with serious risks including pancreatitis and gallbladder disease requiring urgent medical attention
Depending on the patient, monitoring may include: Weight trends Waist circumference Blood pressure Glucose and A1C Lipids Liver markers Kidney markers Thyroid markers when appropriate Nutrient markers when indicated Hormone considerations when relevant Adjust the Plan as the Body Changes A patients needs at the start of treatment may not be the same after losing 20, 40, or 60 pounds
These medications mimic GLP-1, an incretin hormone produced naturally in your gut
Questioning the foundations of the gut microbiota and obesity
The Melanotan 1 compound, marketed pharmaceutically as Scenesse by Clinuvel Pharmaceuticals, is FDA-approved only for the reduction of phototoxicity in adult patients with erythropoietic protoporphyria
Semaglutide is a drug that belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists